stockrowiRhythm Holdings, Inc.
IRTC Healthcare Medical Devices
iRhythm Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $747.1 million, up 26.2% from fiscal 2024.
- Revenue
- +14.9%
- EPS
- −462.5%
- Free cash flow
- −157.6%
- Total debt
- +0.48%
Quarter to September 2026, against a year earlier
Follow IRTC
Alert me
iRhythm Holdings, Inc. (IRTC) Current ratio
iRhythm Holdings, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 3.6×, down 1.1× from fiscal 2025 (4.6×). Over the past ten years it has ranged from 2.1× (fiscal 2023) to 9.0× (fiscal 2016); the current reading is higher than 64% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 4.6× | (20.53%) |
| FY2024 | 5.8× | 170.85% |
| FY2023 | 2.1× | (33.67%) |
| FY2022 | 3.2× | (6.80%) |
| FY2021 | 3.5× | (39.56%) |
| FY2020 | 5.8× | 73.38% |
| FY2019 | 3.3× | (3.48%) |
| FY2018 | 3.4× | (39.86%) |
| FY2017 | 5.7× | (36.31%) |
| FY2016 | 9.0× | 139.90% |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 3.6× | (7.48%) |
| Jun 2026 | 3.9× | (25.37%) |
| Mar 2026 | 5.2× | 11.64% |
| Dec 2025 | 4.6× | (0.05%) |
| 38 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| AXGN AxoGen, Inc. compare | 12.0× |
| TXG 10x Genomics compare | 5.7× |
| TMDX TransMedics Group, Inc. compare | 4.5× |
| ITGR Integer Holdings Corporation compare | 4.0× |
| NEOG Neogen Corporation compare | 3.9× |
| IRTC iRhythm Holdings, Inc. | 3.6× |
| UFPT UFP Technologies, Inc. compare | 3.0× |
| HAE Haemonetics Corporation compare | 2.8× |
| LIVN LivaNova PLC compare | 1.7× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on IRTC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement